All interleukin-13 articles
-
Business
Roche offloads majority of rights to lebrikizumab
Deal with Dermira could be worth well over $1 billion
2017-08-09T13:56:00Z
Deal with Dermira could be worth well over $1 billion
Site powered by Webvision Cloud